Intellipharmaceutics International Inc. (IPCI)

[Amigo Mike]

Angelo,

Assuming a 50-50 split with Mallinckrodt... every 1% of the market that IPCI/MNK capture will be $24 million... or $12 million to IPCI's bottom line... assuming 2.5% penetration IPCI's pure profit would be $30 million a year.

. No expense to IPCI eh ? Pure profit ? Depends on deal. Apparently IPCI wants to be in manufacturing business.

It would be helpful of mgmt to be providing investors more insight into the ANDAs and their current standing with the FDA beyond the boilerplate. Surely the FDA has had contact with IPCI on these applications.

Amigo Mike